Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies

Published:2023 Issue:3 Volume:64 Page:202
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Kim Kyung Hwan¹^ORCID,Lee Hye Won²^ORCID,Ha Hong Koo¹³^ORCID,Seo Ho Kyung²⁴⁵^ORCID

Affiliation:

1. Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.

2. Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea.

3. Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

4. Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Korea.

5. Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Funder

National Cancer Center

Publisher

XMLink

Subject

Urology

Link

https://icurology.org/pdf/10.4111/icu.20230006

Reference100 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Epidemiology and Risk Factors of Urothelial Bladder Cancer

3. Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

4. The prognosis with untreated bladder tumors

5. The natural history of untreated muscle-invasive bladder cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review;Clinical Genitourinary Cancer;2024-04

2. Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties;International Journal of Molecular Sciences;2023-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3